Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 7/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.79 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | APP | P05067 | 3/20 | 0.74 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.70 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.70 |
| ▸ | TUBB | P07437 | 1/20 | 0.70 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.70 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.70 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.70 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.70 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.70 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.70 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.70 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.70 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.70 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.70 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30940355 | 1.00 | CYP1A1 (0.79) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL1815699 | 1.00 | CYP1A1 (0.79) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL9173377 | 0.90 | CYP1A1 (0.84) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL9173364 | 0.90 | CYP1A1 (0.84) | CYP1A1PTGS1PTGS2MAPTAPP | |
| Rhapontigenin SCHEMBL10307426 | 0.89 | CYP1A1 (1.00) | CYP1A1PTGS1PTGS2MAPTAPP | |
| Rhapontigenin SCHEMBL19433130 | 0.89 | CYP1A1 (1.00) | CYP1A1PTGS1PTGS2MAPTAPP | |
| Rhapontigenin SCHEMBL31028358 | 0.89 | CYP1A1 (1.00) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL9431599 | 0.88 | CYP1A1 (0.80) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL9586847 | 0.88 | CYP1A1 (0.80) | CYP1A1PTGS1PTGS2MAPTAPP | |
| SCHEMBL5315843 | 0.87 | TTR (0.80) | PTGS2MAPTAPPCYP1A2NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-3212754-B1 | METHOD OF PRESERVING WINE AND PRESERVED RED WINE | RESWINE LLC (US) | 2023-12-13 | — | — | EP | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-10426742-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2019-01-24 | — | — | US | disclosed |
| EP-2231847-B1 | METHOD AND COMPOSITIONS FOR PRESERVING WINE | RUBIN DAVID (US) | 2018-10-31 | — | — | EP | disclosed |
| EP-3212754-A1 | METHOD AND COMPOSITION OF PRESERVING WINE | Reswine, LLC (US) | 2017-09-06 | — | — | EP | disclosed |
| US-9752110-B2 | Method and compositions of preserving wine | YSDR, LLC (US) | 2017-09-05 | — | — | US | disclosed |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2016-10-13 | — | — | US | disclosed |
| US-9422286-B2 | Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease | WASHINGTON UNIVERSITY (US) | 2016-08-23 | — | — | US | disclosed |
| US-9422286-B2 | Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease | WASHINGTON UNIVERSITY (US) | 2016-08-23 | — | — | US | disclosed |
| WO-2016069654-A1 | METHOD AND COMPOSITION OF PRESERVING WINE | YSDR, LLC (US) | 2016-05-06 | — | — | WO | disclosed |
| US-20150209452-A1 | METAL-BINDING BIFUNCTIONAL COMPOUNDS AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE | WASHINGTON UNIVERSITY (US) | 2015-07-30 | — | — | US | disclosed |
| US-20150209452-A1 | METAL-BINDING BIFUNCTIONAL COMPOUNDS AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE | WASHINGTON UNIVERSITY (US) | 2015-07-30 | — | — | US | disclosed |
| US-20150044328-A1 | METHOD AND COMPOSITIONS OF PRESERVING WINE | Reswine, LLC | 2015-02-12 | — | — | US | disclosed |
| US-8871284-B2 | Method and compositions for preserving wine | YSDR LLC (US) | 2014-10-28 | — | — | US | disclosed |
| US-20110104328-A1 | METHOD AND COMPOSITIONS FOR PERSERVING WINE | Reswine, LLC | 2011-05-05 | — | — | US | disclosed |
| US-20090175984-A1 | METHOD AND COMPOSITIONS FOR PRESERVING WINE | Reswine, LLC | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150209452-A1 | METAL-BINDING BIFUNCTIONAL COMPOUNDS AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE | APBA1, PSEN2, PSEN1 | CYP1A1 3802/4885PTGS1 3649/4885PTGS2 3146/4885 |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | CYP1A1 3239/4885PTGS1 1421/4885PTGS2 2761/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | CYP1A1 2787/4885PTGS1 1642/4885PTGS2 2688/4885 |
| US-10426742-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | CYP1A1 3353/4885PTGS1 1684/4885PTGS2 2804/4885 |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | CYP1A1 3353/4885PTGS1 1684/4885PTGS2 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.